Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer
Status:
Recruiting
Trial end date:
2030-08-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, prospective, randomized, stratified, controlled, open-label study
comparing preoperative FOLFOX versus postoperative risk-adapted chemotherapy in patients with
locally advanced rectal cancer and low risk for local failure
Phase:
Phase 3
Details
Lead Sponsor:
Ralf Hofheinz
Collaborators:
Deutsche Krebshilfe e.V., Bonn (Germany) German Rectal Cancer Study Group Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest